🔴 Cue Biopharma is trading 5% down today as oil and Treasury yields rise

Cue Biopharma is trading at $29.81, down 5.09%, amid broader market weakness.

• No clear new company-specific catalyst was identified for September 28; positive CUE-221 Phase 2 results came September 20, before the recent pullback.
• Oil and Treasury yields rose after President Trump rejected Iran’s proposal, renewing inflation concerns; Reuters reported Monday that shares were mostly lower.
• The supplied index context shows the S&P 500 and Nasdaq down more than 0.5%, consistent with a broader risk-off backdrop.